Drugs That Lack Single-Agent Activity: Are They Worth Pursuing in Combination?

Nat Rev Clin Oncol. 2017 Apr;14(4):193-194. doi: 10.1038/nrclinonc.2017.27. Epub 2017 Mar 7.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / epidemiology
  • Palliative Care